RIPK2:癌症治疗的一个有希望的目标
Jieqiong You1,2,3, Ying Wang1,2, Haifeng Chen3
1Shanghai Frontier Health Pharmaceutical Technology Co. Ltd, Shanghai, China.
Frontiers in pharmacology
|June 16, 2023
概括
受体相互作用的氨酸/氨酸蛋白激酶-2 (RIPK2) 在免疫和炎症中至关重要. 研究评估RIPK2作为一个有前途的抗瘤药物标,探索用于癌症治疗的小分子抑制剂.
科学领域:
- 免疫学 免疫学 免疫学
- 分子生物学分子生物学
- 在瘤学瘤学.
背景情况:
- 通过NOD1/2信号传递,受体相互作用的氨酸/氨酸蛋白激酶-2 (RIPK2) 通过NOD1/2信号传递调解炎症和天生的免疫力.
- NOD2-RIPK2通路激活NF-κB和MAPK,促进促炎性细胞因子的转录.
- 这种途径的失调与自身免疫性疾病有关.
研究的目的:
- 评估将RIPK2作为一种抗瘤药物向的可行性.
- 总结关于RIPK2抑制剂的当前研究.
- 分析小分子RIPK2抑制剂在癌症治疗中的潜力.
主要方法:
- 对RIPK2在免疫和癌症中的作用的文献综述.
- 对RIPK2抑制剂的现有研究进行分析.
- 评估RIPK2在瘤学中的治疗潜力.
主要成果:
- RIPK2在瘤发生和恶性进展中发挥作用.
- 药物抑制RIPK2是一种有前途的策略.
- 针对RIPK2的小分子抑制剂正在研究中.
结论:
- RIPK2是一种可行的抗瘤药物标.
- 对RIPK2抑制剂的进一步研究对于癌症治疗是有必要的.
- 小分子抑制剂显示出抗癌疗法的潜力.
相关概念视频
Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K
Inhibition of Cdk Activity
4.8K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.8K
The Retinoblastoma Gene
4.1K
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
4.1K
M-Cdk Drives Transition Into Mitosis
5.6K
Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
5.6K
Abnormal Proliferation
4.6K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K
Transducer Mechanism: Enzyme-Linked Receptors
2.5K
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
2.5K


